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ABSTRACT: An essential process in predicting the in vivo
pharmacological activity of a candidate molecule involves the
evaluation of target responses using established model systems.
While these models largely comprise immortalized cells, which are
often serially passaged as monolayers on uniformly stiff substrates
and are modified to overexpress one or more components of the
pathway-of-interest, the importance of cell identity, heterogeneity,
and three-dimensional (3D) context to target response is gaining
increasing attention. Here, we assess intracellular calcium responses
in mouse mammary epithelial cells in three distinct model systems:
3D primary organoids, 2D primary epithelial cells, and 2D
immortalized cells. Specifically, we assess intracellular calcium
responses to a number of extracellular signals implicated in the
regulation of basal (or myoepithelial) cell function. These findings provide further insights into cell type and context-specific
pharmacological responses in mammary epithelial cells and highlight the opportunities and challenges in the adoption of
architecturally complex and heterogeneous in vitro assays in pharmacological research.
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Essential to the process of drug discovery is understandingthe way in which model systems respond to target (e.g.,
receptor and channel) modulation. Typically, these model
systems take the form of two-dimensionally (2D) cultured,
serially passaged cell lines, which are assumed to adequately
reflect the behavior of cells within the tissue from which they
were originally derived. While convenient (e.g., in terms of cost,
labor, accessibility, and adaptability to high throughput
screening methods), there are increasing concerns regarding
the ability of immortalized cell lines to accurately predict drug
responses in vivo. 2D immortalized cell culture models not only
frequently differ in their phenotypic characteristics relative to
their in vivo counterparts1 but also have a lack of cell−cell and
cell−extracellular-matrix interactions which further complicates
the interpretation of responses to various stimuli in vitro.2 In the
case of mammary epithelial cells, the influence of 3D cellular
architecture on stimulus response has been appreciated for some
time.3,4 Currently, the ability to monitor cell response and signal
transduction processes downstream of target stimulation in real-
time and in situ is limited to a few model organisms and activity
readouts and is generally associated with high costs and low
throughput.5,6 Realizing the limitations associated with 2D cell
culture systems and in vivo imaging, there has been increasing
interest in moving toward the use of 3D organoids as a more
physiologically relevant model for assessing cellular responses in
vitro [recently reviewed in refs 7 and 8]. Unlike many
immortalized cell-line-based 3D culture models, primary cell
derived organoid cultures can maintain some of the cellular
heterogeneity observed in the tissue of origin, including the
presence of stem/progenitor and differentiated cell types.
Oxygen and nutrient availability in these models is also easier
to control compared to alternative 3D approaches (e.g., explant
culture). Moreover, when grown in the presence of specialized
growth factor cocktails, long-term culture can be achieved, a
feature that is being leveraged for the creation of organoid
“biobanks” for applications in disease modeling and drug
screening.9−11
Intracellular calcium mobilization is a useful readout for
measuring real-time cellular responses to target stimulation and
is often employed as a surrogate for pharmacological activity in
vitro, for example, small-molecule-mediated modulation of G
protein-coupled receptor (GPCR) activity.12,13 Typically, in
vitro intracellular calcium readouts are based on fluorescent
signals measured in cells loaded with synthetic dyes, such as
Fura-2 (ratiometric) and Fluo-4 (nonratiometric).14 While
convenient to use and amenable to ratiometric imaging,
experimental artifacts due to dye sequestration or uneven/
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poor loading are not uncommon, and (owing to their eventual
efflux) small molecule fluorescent indicators are not suited to
long-term (>30−60 min) imaging. More recently, researchers
have started turning to genetically encoded calcium indicators
(GECIs), improved through multiple rounds of structure-
guided design, as a tool to measure intracellular calcium
responses, and their utility in high-throughput drug discovery is
now being evaluated.15,16 Unlike synthetic dye indicators,
GECIs are incorporated into the host cell genome using
standard molecular biology techniques, allowing for lineage-
restricted expression and enabling imaging over periods of hours
to days.16 Advances in GECI targeting and live imaging
platforms are also enabling visualization of calcium responses
at subcellular resolution, including subplasma membrane
domains and endoplasmic reticulum (ER) calcium responses,17
providing greater spatiotemporal information in the engagement
of this highly context-dependent signal transduction system.
The aim of this study was to determine the utility of activity
imaging of agonist responses in dimensionally and biologically
complex systems for pharmacological assays. This was achieved
by comparing calcium signaling responses of mammary
epithelial cells to physiologically relevant agonists using three
distinct in vitromodels2D primary cell culture, 3D (organoid)
primary cell culture, and 2D immortalized cell culturein order
to assess the contribution of cell identity and context to stimulus
response. We show that primary 2D cultured cells and 3D
organoids display similar calcium responses to different stimuli,
which is distinct from those observed in immortalized mammary
epithelial cells. Our findings support the hypothesis that cell
identity, history, and context play an important role in receptor
activation and may be more useful in understanding cellular
responses to endogenous and exogenous agonists. Increased
heterogeneity and dimensionality, however, provide additional
challenges in analyzing and interpreting these data. Never-
theless, the increasing adoption of primary culture and organoid
models, their combination with activity probes (e.g., calcium
and voltage) and continued advances in imaging and image
analysis, will undoubtedly spur further interest in these models
as additional tools for drug discovery pursuits within both
academia and industry, particularly those studies seeking to
assess drug response and toxicity in breast cancer, which is also
highly context-dependent.
■ RESULTS AND DISCUSSION
Mammary Epithelial Architecture Is Absent in 2D
Primary and Immortalized Cell Culture. The mammary
epithelium is a dynamic and plastic structure, which plays an
important role in mammalian offspring survival.18−21 Encircling
a hollow lumen, which acts as a conduit for the passage of milk
during lactation, is a well-defined epithelial bilayer, comprising
an inner luminal cell layer and an outer basal cell layer,
supported by a basement membrane (Figure 1A andMovie S1).
Epithelial cell behaviors in this branching ductal network are
guided by a range of extracellular factors, including diffusive
cues, paracrine/juxtacrine signals, and physical interactions with
both neighboring cells and the extracellular matrix.19
Primary cells cultured for short periods of time on 2D
substrates retain cell lineage characteristics that are often altered
or absent in immortalized, serially passaged cell lines.1 Here, we
show that lineage identity is retained in short-term (overnight)
culture of primary mammary epithelial cells, as indicated by the
presence of distinct cytokeratin (K)8+ (luminal) and K5+ (basal)
epithelial cell populations, as observed in vivo22,23 (Figure 1B).
In monolayer-cultured HC11 immortalized mouse mammary
epithelial cells, however, in addition to distinct K8+ and K5+
populations, 14 ± 3.7% were K8+/lo, K5− and showed nuclear
reactivity to the basal marker p63 (Figure 1C). The presence of
dual-labeled K8+/lo and p63+ cells may represent a characteristic
potentially related to the reported “stem-like” capacity of this
cell line24 or, more likely, this may be a consequence of
phenotypic alterations commonly observed in immortalized,
serially cultured cell lines.1 As expected, 2D cell culture methods
suffer from a complete loss of cellular architecture and tissue
context (Figure 1A versus 1B,C). Loss of architecture may be
associated with altered signal transduction and cellular
dynamics, including proliferation,25,26 metabolic activity,2 and
drug response.2,3,27 The impact of culture conditions on cellular
signaling and drug handling is of particular relevance in early
drug development and discovery, which has traditionally relied
on 2D cell culture models, prompting a search for more
physiologically relevant systems.28−30
3D Mammary Organoids Recapitulate the Organiza-
tional Complexity of the Ductal Epithelium in Vitro. An
appreciation of the importance of cell−cell and cell−
extracellular-matrix interactions in epithelial biology has led to
the development of sophisticated 3D cell culture systems, which
more closely recapitulate the complexity of organ systems in
vivo.29,31 Tissue-derived organoids represent one such model
that is increasingly used to study epithelial cell biology and
disease9 and more recently in drug discovery.28 Using a
previously described protocol,32 we created mammary organo-
ids that exhibit an inner luminal K8+ cell layer and an outer basal
K5+ cell layer, surrounding a hollow lumen (Figure 2A).
However, in some organoids, regions comprising discontinuous
Figure 1. Structural complexity of mammary gland tissue is absent in
2D monolayer culture. (A) 3D maximum intensity projection of
optically clear intact mammary gland tissue showing SMA+ (green)
basal epithelial cells and K8+ (red) luminal epithelial cells. Nuclei are
stained with DAPI (blue). The indicated depth (z) is relative to the first
image acquired in the image series. Representative image from n = 3
mice. (B) Phase contrast (left) and confocal immunofluorescence
(right) images of primary mammary epithelial cells grown in 2D
monolayer culture. K5+ (green) basal and K8+ (red) luminal epithelial
cell populations are observed. Nuclei are stained with DAPI (blue).
Representative images of cells from n = 3 mice. (C) Confocal
immunofluorescence image of 2D mouse mammary HC11 cells
showing expression of luminal (K8, red) and basal (K5, green and
p63, gray) markers. Yellow arrows indicate cells that are K8+/lo, K5− and
nuclear p63+. Nuclei are stained with DAPI (blue). Images are
representative of n = 3 independent experiments.
ACS Pharmacology & Translational Science pubs.acs.org/ptsci Article
https://dx.doi.org/10.1021/acsptsci.9b00090
ACS Pharmacol. Transl. Sci. 2020, 3, 63−75
64
and/or multiple layers of cells were observed (Figure S1).
Although this represents a departure from the in vivo ductal
architecture, multiple luminal cell layers have been observed in
other mammary organoid culture protocols, where they have
been suggested tomimic the body region of terminal end buds.33
We also observed heterogeneous budding structures in some
organoids, as previously reported32 (Figure 2B). Both of these
features were more frequently seen with prolonged periods in
culture (≥14 days). For the purposes of this focused study, we
compare the utility and relevance of 2D and 3D short-term
mammary culture models for real-time imaging in pharmacology
research.
Development of a Genetically Engineered Mouse
Model for Lineage-Specific Assessment of Intracellular
Calcium Signaling in Vitro. The calcium ion is an important
second messenger that plays a role in a number of signaling
pathways relevant to drug discovery research. Increases in
intracellular calcium can occur in mammary epithelial cells, for
example, downstream of activation of certain G-protein coupled
receptors [e.g., the oxytocin (OT) receptor],6 tyrosine kinase
receptors [e.g., the epidermal growth factor (EGF) receptor],34
and ligand-gated ion channels [e.g., P2X receptors].34 Assess-
ment of intracellular calcium responses using synthetic dyes
(e.g., Fura-2 and Fluo-4) or genetically encoded calcium
indicators (e.g., GCaMP6f) can therefore offer a rapid, reliable,
and proportional readout for receptor activation in pharmacol-
ogy studies.35
Recently, OT-stimulated calcium oscillations were visualized
in basal epithelial cells and linked to cell contraction and milk
ejection in ex vivo mammary tissue harvested from lactating
GCaMP6f;K5CreERT2 mice.6 In this model, tamoxifen
administration induces the selective expression of GCaMP6f
in >95% of basal cells6 (Figure 3A), where it is capable of
detecting increases in intracellular calcium with high sensitivity
and fast kinetics.6,36 Although valuable for mapping signal-
response relationships at the tissue level, these ex vivo “explant”
studies are laborious, expensive, and technically challenging,
limiting their scope for medium- to high-throughput drug
screening.
Using optically cleared mammary tissue from GCaMP6f;K5-
CreERT2 mice and an anti-GFP antibody that recognizes
GCaMP6f, expression and lineage specificity of GCaMP6f was
confirmed in smooth muscle actin (SMA)+, K8− basal epithelial
cells from nonpregnant (virgin) mice (Figure 3B), as previously
characterized.6 We also confirmed that GCaMP6f expression
was primarily restricted to basal cells in dissociated mammary
epithelial cells in primary 2D culture (Figure 3C) and in 3D
organoid culture (Figure 3D). A small fraction of GCaMP6f+
cells that were p63− or K5− were observed in primary 2D cell
culture (Figures 3C and S2). As we did not detect any
ambiguously or promiscuously labeled GCaMP6f+ cells in situ or
in 3D organoid studies, we hypothesize that a minor fraction of
primary cells cultured overnight on a 2D substrate dedifferen-
tiate, a well-recognized limitation associated with in vitro 2D
culture of cell types that are highly dependent on micro-
environmental signaling.26,37,38 Having established expression of
GCaMP6f in primary basal cells and basal cells in 3D organoids,
we next assessed calcium signaling dynamics in these distinct
systems to determine whether agonist responses differ in 2D
versus 3D systems, as reported for other cell signaling events.2,39
Basal Mammary Epithelial Cell CalciumResponses Are
Similar in 3D versus 2D Primary Cells but Not
Immortalized Cells. As mentioned, ligand-induced cytosolic
calcium increases provide a useful readout for assessing cellular
responses to exogenous stimuli and represent a method
frequently employed in pharmacology research.14 Such studies
are largely performed using immortalized, serially passaged,
monolayer cell cultures loaded with cell permeant calcium dyes.
Using cells derived from GCaMP6f;K5CreERT2 mouse
mammary tissue (Figure 3A), we were able to compare calcium
responses of basal epithelial cells in both 2D and 3D culture,
without the need of exogenously applied calcium sensitive dyes.
To do this, we selected three physiologically relevant but distinct
ligands: OT, adenosine 5′-triphosphate (ATP), and the
wingless-type MMTV integration site family member 5a
(Wnt5a). OT has a well-established role in regulating basal
epithelial function in the functionally mature mammary gland,
where it acts on the OT receptor, a GPCR that signals via
intracellular calcium release, leading to a contractile response
that is essential for milk expulsion in lactation.6,40 The
extracellular purine nucleotide ATP is recognized for its role
in neurotransmission and secretory processes, but it is now also
known to contribute to various pathologies, including
inflammation41 and tumor progression.42 ATP-mediated
cytosolic calcium increases occur downstream of purinergic
receptor activation, which includes members of the P2X
ionotropic and P2Y metabotropic families.41 Similar to OT,
ATP has been shown to act directly upon myoepithelial cells,
including those in the lacrimal and mammary gland, eliciting a
measurable calcium response.43,44 WNT ligands play important
roles in mammary gland development and include the
noncanonical WNT ligand, Wnt5a, which is implicated in the
regulation of stem/progenitor activity and ductal epithelial
growth and side branching.45,46 While calcium has been shown
to transduceWnt5a signaling events in other cell types,47−49 less
is known about the pathways by which this ligand mediates its
effects in mammary epithelial cells. Recently, the receptor
tyrosine kinase-like orphan receptor 2 (ROR2) and receptor-like
tyrosine kinase (RYK) were identified as likely candidates;46,50
Figure 2. Mammary organoids maintain a physiologically relevant
epithelial cell bilayer in vitro. (A) Confocal immunofluorescence images
of mammary organoids grown for up to 21 days in culture. K5+ (green)
basal epithelial cells and K8+ (red) luminal epithelial cells form a
distinct bilayer surrounding a central lumen in mammary organoids
grown in vitro. Nuclei are stained with DAPI (blue). The indicated
depth (z) is relative to the first image acquired in the image series. (B)
Phase contrast images of mammary organoids. Images are representa-
tive of organoids from n = 3 mice.
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calcium activation downstream of these pathways in 2D or 3D
mammary epithelial cell cultures, however, remains entirely
unexplored.
It is a well-appreciated phenomenon that when cultured on
stiff 2D substrates primary cells may undergo a process of
dedifferentiation resulting in phenotypic changes.26,37 For this
reason, we performed all calcium studies on 2D primary cells
within 24 h of dissection (Figure 4A−E). Under these
conditions, we observed heterogeneous (amplitude and
frequency) calcium responses6,51 in GCaMP6f+ cells following
addition of OT. This response was characterized by an initial
large and transient rise in intracellular calcium ([Ca2+]i) in
nearly all cells followed by subsequent, typically smaller calcium
oscillations (Figures 4A and S3; Movie S2). These observations
were confirmed using the automated calcium signal spike
analysis tool, CaSiAn52 (see the Methods and Figure 4E).
Similarly, ATP stimulation produced a large initial calcium
transient, which may involve activation of both P2X-mediated
extracellular calcium influx as well as P2Y-mediated intracellular
calcium release53 (Figures 4B,E and S3; Movie S3). Publically
available RNA sequencing data suggests that a number of P2X
and P2Y receptors are expressed in basal epithelial cells from
virgin mouse mammary gland,54 and we confirmed in our
laboratory that P2rx1, P2rx4, P2rx5, P2ry1, P2ry2, and P2ry6 are
expressed in mouse mammary tissue, via quantitative RT-PCR
(Figure S4A). Both the initial and subsequent calcium responses
of 2D primary cells toWnt5a were of lower amplitude compared
to those seen following treatment with OT and ATP, with
Figure 3. In vitro model for the lineage-specific assessment of calcium-dependent signal transduction. (A) Schematic representation of the induction
schedule for the conditionalGCaMP6f;K5CreERT2 knock-inmousemodel. (B) 3Dmaximum intensity projection of optically clearedmammary gland
tissue showing lineage-specific expression of GCaMP6f (green) in SMA+ (red) basal epithelial cells (left). GCaMP6f+ cells (green) are distinct fromK8
expressing (magenta) luminal epithelial cells (right). Nuclei are stained withDAPI (blue). The indicated depth (z) is relative to the first image acquired
in the image series; n = 2mice. (C)Confocal immunofluorescence images of 2D primary cells showing lineage-specific expression of GCaMP6f (green)
in nuclear p63+ (red) basal epithelial cells. White arrows indicate GCaMP6f+, p63+ cells. The arrow head indicates a GCaMP6f+, p63− cell. Images are
representative of n = 3 mice. (D) 3D maximum intensity projection of GCaMP6f;K5CreERT2 mammary organoid showing the GCaMP6f+ (green),
p63+ (red) outer basal epithelial cell layer (left) surrounding an inner K8+ (magenta) luminal epithelial cell layer (right). Nuclei are stained with DAPI
(blue). The indicated depth (z) is relative to the first image acquired in the image series. Images are representative of n = 3 mice.
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typically only a small number of cells showing delayed transient
responses (either single or oscillatory; Figures 4C,E and S3;
Movie S4). These results may correlate with this agonist
potentially acting on a less abundant population of mammary
stem/progenitor cells.46 Calcium responses following the
addition of physiological salt solution (PSS; buffer) appeared
to be less frequent and of lower amplitude and duration relative
to the responses of the other ligands that were assessed in 2D
primary cells (Figures 4D and S3; Movie S5).
Next, we analyzed agonist-evoked calcium signals in 3D
organoids (Figure 5A−E). Consistent with the calcium response
observed in 2D primary cells, 3D cultured GCaMP6f+ cells
exhibited an initial large and transient rise in [Ca2+]i followed by
smaller calcium oscillations in response to OT stimulation
Figure 4. Lineage-specific assessment of calcium signaling in mammary primary epithelial cells cultured in 2D.Maximum intensity projection showing
global cell calcium response (gray; left), and representative single cell calcium traces showing relative change in fluorescence intensity normalized to
baseline (F/F0) (right) from GCaMP6f;K5CreERT2 2D primary cells following stimulation with (A) OT, (B) ATP, (C) Wnt5a, and (D) PSS. Yellow
arrows indicate cells that demonstrate repetitive calcium oscillations (≥2 per imaging series). Red arrows indicate cells that demonstrate a single
calcium response. Representative of movies from n = 3 animals. (E) Quantitative analysis of calcium responses to agonist stimulation including, peak
amplitude (peak value (F/F0) of initial and secondary calcium spikes), time between consecutive calcium spikes (interspike interval (s)) and time to
first calcium peak (s). Numbers denoted in bars indicate the number of cells (out of a total of 75) identified as responding to the corresponding agonist.
Graphs showmean± S.E.M., n = 3 independent experiments; #, P < 0.05 in OT and ATP relative toWnt5a-stimulated primary cells, one-way ANOVA
with Bonferroni post-tests.
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(Figures 5A,E and S5; Movie S6). Calcium spikes subsequent to
the initial calcium store−release event in 3D organoids were
generally of lower amplitude and shorter interval relative to 2D
primary cells, an effect that may be due to context-dependent
influences, as has been shown in 2D versus 3D neuronal cell
cultures.55 Organoid responses to ATP stimulation were
characterized by an initial large and transient rise in [Ca2+]i,
followed by oscillatory events of lower amplitude, similar to
those observed in ATP treated 2D primary cells (Figures 5B,E
and S5; Movie S7). As seen for 2D primary cells, a small fraction
of GCaMP6f+ cells in 3D organoids displayed low amplitude,
irregular calcium responses (as indicated by variable interspike
interval) following treatment with Wnt5a (Figures 5C,E and S5;
Movie S8), a response that appeared to be distinct from basal
Figure 5. Lineage-specific assessment of agonist evoked Ca2+ responses in mammary 3D organoids. Maximum intensity projection showing global cell
calcium response (gray) (left), and representative single cell calcium traces showing relative change in fluorescence intensity normalized to baseline
(F/F0) (right) from GCaMP6f;K5CreERT2 mammary organoids following stimulation with (A) OT, (B) ATP, (C) Wnt5a and (D) PSS. Yellow
arrows indicate cells that demonstrate repetitive calcium oscillations (≥2 per imaging series). Red arrows indicate cells that demonstrate a single
calcium response. Representative of movies from n = 3 (OT, ATP andWnt5a) and n = 2 animals (PSS). (E) Quantitative analysis of calcium responses
to agonist stimulation including, peak amplitude (peak value (F/F0) of initial and secondary calcium spikes), time between consecutive calcium spikes
(interspike interval (s)). Numbers denoted in bars indicate the number of cells (out of a total of 75) identified as responding to the corresponding
agonist. Graphs show mean ± S.E.M., n = 3 independent experiments; ##, P < 0.05 in ATP relative to Wnt5a-stimulated primary cells; one-way
ANOVA with Bonferroni post-tests.
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oscillations observed in PSS (buffer)-treated organoids (Figures
5D and S5; Movie S9). While changes in [Ca2+]i in GCaMP6f
+
basal cells responding to Wnt5a stimulation tended to be
delayed in both 2D and 3D primary cells, we did observe one
organoid in which a transient and widespread increase in [Ca2+]i
occurred soon after agonist addition (Figure S5 andMovie S10).
Recent studies have identified differential, receptor-dependent
effects of Wnt5a in distinct mammary stem/progenitor
populations.46 Specifically, Wnt5a inhibits mammary epithelial
side branching via ROR2, while promoting epithelial growth in
mammosphere formation assays via RYK.46 It is, therefore,
possible that the different calcium responses observed in
response to Wnt5a stimulation is associated with the type of
receptor expressed by the responding cell(s) and differential
contributions to polyclonal organoid cultures (Figure S4B).
Using long-term live cell imaging techniques, it would be
Figure 6. Assessment of calcium signaling in the HC11 immortalized mouse mammary epithelial cell line. Maximum intensity projection showing
global cell calcium response (gray) (left), and representative single cell calcium traces showing relative change in fluorescence intensity normalized to
baseline (F/F0) (right) from Fluo4-loaded HC11 cells following stimulation with (A) OT, (B) ATP, (C)Wnt5a, and (D) PSS. Yellow arrows indicate
cells that demonstrate repetitive calcium oscillations (≥2 per imaging series). Red arrows indicate cells that demonstrate a single calcium response,
representative of movies from n = 3 independent experiments. (E) Quantitative analysis of calcium responses to agonist stimulation including, peak
amplitude (peak value (F/F0) of initial and secondary calcium spikes), time between consecutive calcium spikes (interspike interval (s)). Numbers
denoted in bars indicate the number of cells (out of a total of 75) identified as responding to the corresponding agonist. Graphs showmean± S.E.M.; n
= 3 independent experiments, one-way ANOVA with Bonferroni post-tests.
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interesting to assess the association between the nature of the
Wnt5a-mediated [Ca2+]i response, Wnt receptor expression,
and organoid epithelial side branching.
Collectively, agonist responses in GCaMP6f+ 2D and 3D
primary cell models were largely similar and, with respect to OT
and ATP, exhibited [Ca2+]i profiles characteristic of the specific
receptors and channels implicated in these signaling path-
ways.6,51,56 In order to appreciate the physiological relevance of
subtle differences in signaling dynamics, such as lower
amplitude, higher frequency oscillations following OT-mediated
calcium store−release in organoids, more complex in situ
calcium imaging studies are required.
Serially passaged,monolayer cultures of immortalized cells are
routinely used in early drug discovery and screening studies.30
Therefore, we also assessed [Ca2+]i responses in Fluo-4 loaded
HC11 cells, a mouse cell line commonly utilized in studies
assessing normal mammary epithelial cell biology57,58 (Figures
6A−E and S4A−C). Only a small number of HC11 cells
responded to OT (11/75) (Figures 6A,E and S6; Movie S11)
and ATP (31/75) stimulation (Figures 6B,E and S6; Movie
S12), and these cells typically lacked the calcium release profile
observed in 2D primary cells and organoids (i.e., coordinated
initial calcium store release in response to OT stimulation).
While Wnt5a-mediated signaling processes have been studied
previously in HC11 cells,59 it was difficult to discern a specific
Wnt5a-mediated [Ca2+]i response (with only 2/75 responding
cells identified) (Figures 6C,E and S6; Movie S13) from PSS
(buffer) treated cells (Figures 6D and S6; Movie S14). This may
be due to the mechanism by whichWnt5a reportedly acts in this
cell line, with studies suggesting engagement of the canonical
Wnt/β-catenin/TCF signaling pathway as well as trans-
activation of epidermal growth factor receptor (ErbB1),59
pathways that may not result in calcium release within the
imaging period. To compare all three models, we calculated the
percent responding cells to each agonist in 2D primary cells,
primary organoids, and the HC11 mammary epithelial cell line
(Figure 7). These data reveal that 2D and 3D primary cells are
more responsive to all physiological agonists tested. Together,
our findings show that, while short-term primary 2D and 3D
mammary epithelial cell culture models display similar [Ca2+]i
signaling dynamics in response to physiologically relevant ligand
stimulation, the responses in monolayer cultured HC11 cells are
less representative of the tissue from which they were originally
derived.
■ CONCLUDING REMARKS
Recognition of the need for more physiologically relevant in vitro
models in drug discovery research and preclinical development,
particularly in the context of anticancer agents, has grown
significantly over the past decades.28−30 At the same time, there
is growing appreciation of the value of 4D (x, y, z, and t)
organoid and whole tissue imaging in the study of normal
cellular and tissue dynamics.6,60 Here, we have presented an in
vitromodel whereby [Ca2+]i responses can be assessed following
target stimulation in real-time and in both 2D and 3D, while
avoiding the limitations associated with the use of synthetic
calcium dyes.15 It is worth noting, while our results suggest 2D
primary cells may be a sufficient model for [Ca2+]i signal analysis
in response to direct agonist stimulation, numerous studies have
shown distinct advantages of more complex 3D systems,
particularly in the assessment of anticancer drug activity.28 A
clear benefit of our 3D organoid model over 2D cultured
primary cells, is the potential for its application in studies
requiring long-term (up to weeks) monitoring and multi-
parametric phenotypic analyses. While the GCaMP6f;K5-
CreERT2 mouse model we present in this study allows for
detection of relative cytosolic [Ca2+]i changes in a specific cell
type, the rapidly evolving palette of GECIs available means that
examination of potential cell−cell interactions through genetic
expression of red calcium sensors (e.g., RCaMP) in cocultured
cell populations is also possible.61,62 Coexpression of stably
expressed, calcium-independent reference fluorescent proteins
with distinct excitation and emission characteristics in the same
cell also provides an opportunity for quantitative ratioing, which
may be of particular benefit when assessing calcium responses
that may be linked to changes in cell shape (e.g., cell-rounding).
Despite the progress made in the development of more
complex, physiologically representative 3D models for drug
discovery research, a number of barriers to their routine use
currently exist, including their adaptation to medium- and high-
content screening platforms for improved throughput63 and the
ability to both rapidly acquire and process large sets of imaging
data.28,60,64 With respect to calcium imaging, a number of open-
source post-acquisition calcium signal analysis tools have
recently become available, including CaSiAn52 and Flika,65
with some early analyses performed in 3D systems. The use and
improvement of graphical-user-interfaces (GUIs) in many of
these publicly available tools increases their accessibility to
noncomputational scientists. However, these automated pro-
grams, which are often designed for analyzing calcium spikes in
Figure 7. Assessment of ligand-specific responses in 3D and 2D primary and 2D immortalized mammary epithelial cells. Graphs show percent cells
responding to ligand stimulation in each model (3D and 2D primary cells and HC11 immortalized cell line). Positive cell calcium responses were
determined where maximum signal amplitude (intensity) was >2 AFU. For each ligand, n = 3 independent experiments, and PSS, n = 3 (2D primary
and HC11 cells) or n = 2 (3D primary cells) independent experiments (25 randomly selected cells per experiment) were assessed. Graphs show mean
± S.E.M.; #, P < 0.05 in 3D and 2D primary cell models versus HC11 immortalized cells, one-way ANOVA with Bonferroni post-tests.
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excitable cells,52 can often fail to appropriately detect slow and
noisy oscillations in epithelial cell populations, reducing the
speed and accuracy of feature extraction. Finally, optimization of
3D matrices that both provide appropriate factors for organoid
growth and improve batch to batch consistency, a current
limitation of animal derived basement membrane extracts (e.g.,
Matrigel) and that are compatible with high-throughput
automation is also required.64
In conclusion, by comparing [Ca2+]i responses of primary cell
derived 3D organoid, 2D primary cells, and an immortalized cell
culture model, our findings add to the growing body of literature
suggesting that adoption of more complex biological models as
tools in drug discovery may help to capture the true
heterogeneity of living mammalian systems and improve the
translatability of in vitro responses in drug discovery and
preclinical screening.
■ MATERIALS AND METHODS
Mice. Animal experimentation was carried out in accordance
with the Australian Code for the Care and Use of Animals for
Scientific Purposes and the Queensland Animal Care and
Protection Act (2001), with local ethics committee approval.
Animals were housed in a specific-pathogen-free (SPF) facility
in individually ventilated cages with standard enrichment under
a 12:12 h light−dark cycle. Regular mouse chow and water were
available ad libitum. K5-CreERT2 mice (B6N.129S6(Cg)-
Krt5tm1.1(cre/ERT2)Blh/J, stock no. 029155) were sourced from
The Jackson Laboratory (Bar Harbor, ME). GCaMP6f-fl mice
(B6J.Cg-Gt(ROSA)26Sortm95.1(CAG‑GCaMP6f)Hze/MwarJ) were a
gift from Dr. James W. Putney Jr. (National Institutes of
Environmental Health Sciences, NC). C57BL6 (used for tissue-
clearing studies) were obtained from the Animal Resources
Centre (Western Australia). Mice were maintained on a
C57BL6 background as heterozygotes. Female animals were
used experimentally and were sacrificed postpuberty, between
21 and 33 weeks of age.
DNA extracted from mouse toe, ear, or tail was used for
genotyping with the following primers: K5-CreERT2 5′-GGA
GGA AGT CAG AAC CAG GAC-3′, 5′-GCA AGA CCC TGG
TCC TCA C-3′, 5′-ACC GGC CTT ATT CCA AGC-3′ (PCR
product size: wild type 322 bp, mutant 190 bp), and GCaMP6f-
fl 5′-CTC TGC TGC CTC CTG GCT TCT-3′, 5′-CGA GGC
GGA TCA CAA GCA ATA-3′, and 5′-TCA ATG GGC GGG
GGT CGT T-3′ (PCR product size: wild type 330 bp, mutant
250 bp).
GCaMP6f was induced by administering 1.5 mg of tamoxifen
(Sigma, T6548) prepared in sunflower seed oil (Sigma, S5007)
and ethanol (10%) via intraperitoneal injection at 28, 56, and 58
days of age.
Mammary Organoids. Mammary organoids were created
from the fourth mammary glands (with inguinal lymph nodes
removed) of GCaMP6f;K5CreERT2 virgin mice, as previously
described,6,32 with the following modifications. Tissue was
dissociated by chopping briefly with scalpel blades and placing in
a digestion mix before transferring to a gentleMACS Dissociator
(Miltenyi Biotec) and running program 37C_m_LDK_1
(gentle mechanical agitation at 37 °C for 31 min). Organoid
medium was replaced 3 times per week, and organoids were
maintained for 7−21 days. Organoids were nonenzymatically
passaged in fresh Cultrex Reduced Growth Factor Basement
Membrane Extract (R&D Systems, RD343300501, Lot:
39795F17) into a μ-Dish (Ibidi, 81158) 1−2 days prior to live
imaging.
Organoids were incubated with CellTracker Red (6 μM,
ThermoFisher Scientific, C34552) at 37 °C with 5% CO2 for
20−30 min prior to imaging. Live imaging was performed in
physiological salt solution (PSS, pH 7.3−7.4) [HEPES (10
mM), KCl (5.9 mM), MgCl2 (1.4 mM), NaH2PO4 (1.2 mM),
NaHCO3 (5 mM), NaCl (140 mM), glucose (11.5 mM), and
CaCl2 (1.8 mM)], and organoids were stimulated with
adenosine 5′-triphosphate (ATP, 100 μM, Sigma, A6419),
oxytocin (85 nM, Sigma, O3251), Wnt5a (100 ng/mL, R&D
Systems, 645-WN-010), or PSS. Images were acquired every
4.060−4.084 s (total scan time = 27 min) on an Olympus
FV3000 inverted confocal laser scanning microscope with
resonant scanner and using a UPLSAPO 30×/1.05 silicone
objective. Agonist additions were made between 40−50 s from
the start of imaging.
Primary Cells. 2D primary cell cultures were prepared in
parallel to organoids. Following mammary gland dissociation,
cells were counted and suspended in 2D primary cell culture
media [DMEM/F12 (ThermoFisher Scientific, 11330032) with
10% FCS and 1× penicillin/streptomycin (ThermoFisher
Scientific, 15140122)]. Approximately 2.5 × 104 cells/5 μL
were spotted on the bottom of an imaging dish and left for 4−6 h
at 37 °Cwith 5%CO2 in a humidified incubator to adhere before
the addition of 2D primary cell culture media.51 2D primary cell
experiments were performed within 24 h of plating.
For live imaging experiments, primary cells were incubated
with CellTracker Red and stimulated with agonists as described
in the above section. Images were acquired every 2 s (total scan
time 10 min) as described for mammary organoids. Agonist
additions were made approximately 40 s from the commence-
ment of imaging.
HC11 Cell Culture. Immortalized HC11 mammary
epithelial cells,58 a gift from Prof. Melissa Brown (The
University of Queensland, Australia), were cultured in RPMI-
1640 (Sigma, R8758) supplemented with fetal calf serum
(Thermo Fisher Scientific, 10099141, 10%), bovine insulin
(Sigma, I6634, 5 μg/mL), and murine epidermal growth factor
(Sigma, E4127, 10 ng/mL). Cells were maintained at 37 °Cwith
5% CO2 in a humidified environment and routinely tested
negative to mycoplasma infection (MycoAlert; Lonza, LT07−
218).
For calcium studies, HC11 cells were loaded with 4 μM
Fluo4-AM (F14201, ThermoFisher Scientific) for 20 min at 37
°C. Following dye incubation, cells were washed 1× with PSS
containing 0.3% BSA, followed by PSS only. Agonist stimulation
and image acquisition were performed as detailed above for 2D
primary cell experiments.
Immunofluorescence Staining.HC11 andGCaMP6f;K5-
CreERT2 2D primary cells were washed gently with phosphate-
buffered saline (PBS), fixed in paraformaldehyde (PFA, 4%) for
15 min at room temperature, and permeabilized in ice cold
methanol for 10 min on ice. Cells were blocked for 1 h at room
temperature before primary antibody incubation overnight at 4
°C. The following primary antibodies were used in this study:
chicken anti-green fluorescent protein (GFP; 1:2000, Abcam,
ab13970), rabbit anti-keratin 5 (K5; 1:100, Biolegend, 905503),
rat anti-keratin 8 (K8; 1:200, Developmental Studies Hybrid-
oma Bank, TROMA-I), and rabbit anti-p63 (1:100, Abcam,
ab124762). The following secondary antibodies were used in
this study (at a dilution of 1:500): goat anti-chicken Alexa Fluor
488 (Life Technologies, A11039), goat anti-rat Cyanine3 (Life
Technologies, A10522), goat anti-rabbit Alexa Fluor 647 (Life
Technologies, A21245), and goat anti-mouse Alexa Fluor 647
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(Life Technologies, A21236). Nuclei were counterstained with
DAPI (5 μg/mL) for 15 min at room temperature. Image
acquisition was performed using an Olympus FV3000 laser
scanning confocal microscope with UPLSAPO 20×/0.75 and
UPLSAPO 10×/0.4 air objective lenses. Post-acquisition image
visualization and processing was performed with ImageJ
(v1.52e, National Institutes of Health).66 Images have been
brightness and contrast adjusted for publication.
GCaMP6f;K5CreERT2 organoids were fixed in PFA 4% for 30
min at room temperature and permeabilized in PBS with 0.2%
Triton X-100 for 15 min at 37 °C. Organoids were blocked for 1
h at 37 °C before primary antibody incubation for 2 h at 37 °C.
The following primary antibodies were used in this study:
chicken anti-green fluorescent protein (GFP; 1:2000), rabbit
anti-keratin 5 (K5; 1:150, Biolegend, 905503), rat anti-keratin 8
(K8; 1:50−1:100), and rabbit anti-p63 (1:100). Nuclei were
counterstained with DAPI (5 μg/mL) for 15 min at room
temperature. Image acquisition and processing was performed as
described above for 2D cells.
Tissue Clearing.Mouse mammary tissue was dissected and
fixed for 6−9 h in neutral buffered formalin solution (10%,
Sigma, HT501128) and tissue clearing performed using a
modified CUBIC protocol (CUBIC 1A) as previously
described.22,67,68 The following primary antibodies were used
in this study: chicken anti-green fluorescent protein (GFP;
1:2000), rat anti-Keratin 8 (K8; 1:50) and rabbit anti-alpha
smooth muscle actin (SMA; 1:300, Abcam, ab5694). Nuclei
were counterstained with DAPI (5 μg/mL) for 2 h at room
temperature. Following staining, cleared tissue was immersed in
CUBIC Reagent 2 for a minimum of 24 h prior to imaging.
Image acquisition was performed using an Olympus FV3000
laser scanning confocal microscope with UPLSAPO 20×/0.75
and UPLSAPO 10×/0.4 air objective lenses. Post-acquisition
image visualization and processing was performed with ImageJ
(v1.52e, National Institutes of Health),66 and denoising was
performed as previously described.69
RNA Analysis. RNA extractions were performed using the
RNeasy PlusMini Kit with gDNA eliminator columns according
to the manufacturer’s instructions (Qiagen, 74134). Briefly,
HC11 cells were lysed directly in RLT Buffer Plus, while fresh
frozen mammary gland tissue was first crushed to a fine powder
using a mortar and pestle over dry ice before suspending in RLT
Buffer Plus. HC11 cDNA was prepared using the Omniscript
RT Kit (Qiagen, 205113), while cDNA from fresh frozen tissue
was prepared using the Quantitect RT Kit, which includes an
additional gDNA removal step (Qiagen, 205311). Gene
expression levels were assessed using the following prevalidated
TaqMan Gene Expression Assays (Applied Biosystems): Oxtr
(Mm01182684) , P2 r y1 (Mm02619947) , P2 r y2
(Mm02619978) , P2 r y6 (Mm02620937) , P2 rx1
(Mm00435460) , P2 rx4 (Mm00501787) , P2 rx5
(Mm00473677), Ryk (Mm01238551), Ror1 (Mm00443462),
and Ror2 (Mm00443470). Ct values were then normalized to
the reference gene, 18S rRNA, and relative mRNA levels are
expressed as −ΔCt.53
Cell Ca2+ Analysis.Calcium signals were extracted in ImageJ
using the Time Series Analyzer V3 plugin. Maximum intensity
projections were created from image stacks and 25 predefined
regions of interest were assigned at random based on the first
imaging frame (prior to agonist stimulation). Changes in
calcium signal intensity were calculated based on starting
fluorescence (F/F0), and calcium traces were plotted in
GraphPad Prism (v7.03). Images have been brightness- and
contrast-adjusted for publication. For analysis of calcium spike
trains, normalized fluorescence values (F/F0) were imported
into CaSiAn.52 Nonresponding cells were considered to have a
peak amplitude (intensity) less than 2 AFU and were excluded
from further analyses. Automatic peak and nadir detection was
performed in CaSiAn using a peak threshold of 15% of the
maximum peak amplitude. In some cases, however, the program
failed to accurately detect calcium spikes (Figure S7A). Calcium
oscillations in basal epithelial cells are slow, and unlike many
other characterized cell types, successive calcium spikes can
arrive before the signal has returned to baseline levels (Figure
S7B (i−iii)), leading to problems in peak and nadir detection.
■ STUDY LIMITATION
This is a proof-of-concept study comparing agonist responses in
biologically complex versus traditional cell-based assays. The
authors acknowledge a limitation of this study is the assessment
of a single concentration of each agonist for the activity readout
in each model. Subsequent studies assessing concentration−
response relationships are warranted.
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